Last Week in Weed: Mar. 3rd- Mar. 10th, 2025
Welcome to the latest edition of “Last week in Weed,” catching you up on the latest breaking news and industry developments in the world of cannabis.
Here’s what you may have missed over the last week:
MariMed Acquires First State Compassion for $11 Million
In a strategic move to bolster its presence in the medical cannabis sector, MariMed has finalized an $11 million acquisition of First State Compassion. This purchase expands MariMed’s footprint in Delaware, enhancing its capacity to serve patients with quality medical cannabis products. The acquisition will bolster the company’s growth and highlights the increasing demand for medical cannabis.
Scientists Develop Non-Psychoactive Cannabis Compound for Pain Relief
Researchers have engineered a new cannabis compound that offers pain relief without inducing the mind-altering effects typically associated with THC. This development holds promise as a potential alternative to opioids for chronic pain management, addressing the urgent need for non-addictive pain treatments. The breakthrough could majorly alter pain therapy practices and reduce reliance on opioids.
Learn more about this discovery here: Scientists Develop New Cannabis Compound Without Mind-Altering Effects
Glass House Secures $50 Million Loan with Favorable Terms
Glass House Brands has secured a $50 million loan featuring an 8.58% fixed interest rate and an interest-only period for the first two years. This financial arrangement extends the company’s debt maturity to 2030 and is expected to preserve $13.1 million in cash flow over the next two years. The favorable terms of this loan reflect growing confidence in the cannabis industry’s stability and Glass House’s strategic positioning within the market.
British American Tobacco Invests $86.8 Million in Organigram
British American Tobacco (BAT) has made a significant investment of $86.8 million in Organigram, a Canadian cannabis company. This move signals the tobacco giant’s expanding influence in the cannabis sector and aligns with its strategy to diversify beyond traditional tobacco products. BAT’s investment exemplifies the growing interest of established corporations in the burgeoning cannabis industry and may pave the way for further collaborations and innovations.
Georgia Senate Advances Cannabis Legislation
In a significant legislative session, the Georgia Senate passed three bills affecting cannabis regulation. One bill aims to expand medical cannabis access by increasing the allowable THC concentration from 5% to 50% and adding conditions like lupus to the list of qualifying ailments. The other saw a ban THC-infused beverages, citing consumer safety concerns. Additionally, a bill was approved to impose stricter testing and labeling requirements on hemp-derived products, such as Delta-8 and Delta-10 THC, to ensure consumer protection.
The post Last Week in Weed: Mar. 3rd- Mar. 10th, 2025 appeared first on Cannabis & Tech Today.